RU2593778C3 - Фармацевтический продукт, содержащий экстракт(ы) аллергена клещей, и способ его получения - Google Patents
Фармацевтический продукт, содержащий экстракт(ы) аллергена клещей, и способ его полученияInfo
- Publication number
- RU2593778C3 RU2593778C3 RU2012157737A RU2012157737A RU2593778C3 RU 2593778 C3 RU2593778 C3 RU 2593778C3 RU 2012157737 A RU2012157737 A RU 2012157737A RU 2012157737 A RU2012157737 A RU 2012157737A RU 2593778 C3 RU2593778 C3 RU 2593778C3
- Authority
- RU
- Russia
- Prior art keywords
- der
- fraction
- extract
- mites
- pharmaceutical product
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2063—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Insects & Arthropods (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Transplantation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Claims (9)
1. Фармацевтический продукт, содержащий экстракт аллергена, который содержит экстракты из следующих групп (а) - (d):
(a) экстракт тел клещей Der ρ, где экстракт тел клещей Der ρ готовят из одной фракции или объединенной фракции(й) культур клещей, где указанная фракция(и) содержит больше чем 95% об./об. тел клещей Der ρ,
(b) экстракт тел клещей Der f, где экстракт тел клещей Der f готовят из одной фракции или объединенной фракции(й) культур клещей, где указанная фракция(и) содержит больше чем 95% об./об. тел клещей Der f,
(c) экстракт фекальных частиц Der ρ, где экстракт фекальных частиц клещей Der ρ готовят из одной фракции или объединенной фракции(й) культур клещей, где указанная фракция(и) содержит больше чем 95% об./об. фекальных частиц клещей Der ρ,
(d) экстракт фекальных частиц Der f, где экстракт фекальных частиц клещей Der f готовят из одной фракции или объединенной фракции(й) культур клещей, где указанная фракция(и) содержит больше чем 95% об./об. тел клещей Der f,
где экстракт аллергена содержит равные весовые количества аллергена группы 1 и группы 2, и
где фармацевтический продукт представляет собой быстрораспадающуюся сублингвальную таблетку.
2. Фармацевтический продукт по п. 1 для лечения и/или профилактики аллергии или аллергической астмы, вызванной клещами домашней пыли.
3. Применение фармацевтического продукта по п. 1 или 2 для получения медицинского продукта для лечения и/или профилактики аллергии или аллергической астмы, вызванной клещами домашней пыли.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35116410P | 2010-06-03 | 2010-06-03 | |
EP10164879.8 | 2010-06-03 | ||
EP10164879 | 2010-06-03 | ||
US61/351,164 | 2010-06-03 | ||
PCT/EP2011/059210 WO2011151449A1 (en) | 2010-06-03 | 2011-06-03 | Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereof |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2016121600A Division RU2710544C2 (ru) | 2010-06-03 | 2011-06-03 | Фармацевтический продукт, содержащий экстракт(ы) аллергена клещей, и способ его получения |
Publications (3)
Publication Number | Publication Date |
---|---|
RU2012157737A RU2012157737A (ru) | 2014-07-20 |
RU2593778C2 RU2593778C2 (ru) | 2016-08-10 |
RU2593778C3 true RU2593778C3 (ru) | 2020-12-21 |
Family
ID=42983735
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2016121600A RU2710544C2 (ru) | 2010-06-03 | 2011-06-03 | Фармацевтический продукт, содержащий экстракт(ы) аллергена клещей, и способ его получения |
RU2012157737A RU2593778C3 (ru) | 2010-06-03 | 2011-06-03 | Фармацевтический продукт, содержащий экстракт(ы) аллергена клещей, и способ его получения |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2016121600A RU2710544C2 (ru) | 2010-06-03 | 2011-06-03 | Фармацевтический продукт, содержащий экстракт(ы) аллергена клещей, и способ его получения |
Country Status (11)
Country | Link |
---|---|
US (4) | US9265824B2 (ru) |
EP (3) | EP3266460B1 (ru) |
JP (3) | JP6002663B2 (ru) |
KR (2) | KR101893156B1 (ru) |
CN (2) | CN105903012B (ru) |
AU (1) | AU2011260233C1 (ru) |
CA (1) | CA2801125A1 (ru) |
MX (1) | MX2012013892A (ru) |
RU (2) | RU2710544C2 (ru) |
WO (1) | WO2011151449A1 (ru) |
ZA (1) | ZA201300033B (ru) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101893156B1 (ko) * | 2010-06-03 | 2018-08-31 | 알크-아벨로 에이/에스 | 진드기 알레르겐 추출물(들)을 함유하는 의약품 및 그의 제조방법 |
EA024972B1 (ru) * | 2013-08-05 | 2016-11-30 | Ргп На Пхв "Государственный Медицинский Университет Г. Семей" | Способ очистки биомассы клещей dermatophagoides farinae от питательной среды |
US10872313B2 (en) | 2015-06-02 | 2020-12-22 | ROCA Medical Ltd. | Method for repurposing NDC codes in a pharmaceutical database for venom derived allergens involved in venom immunotherapy |
TWI710569B (zh) * | 2014-12-02 | 2020-11-21 | 日商大鵬藥品工業股份有限公司 | 新穎美洲室塵蟎蛋白質 |
NL2014882B1 (en) * | 2015-05-29 | 2017-01-31 | Citeq B V | Allergy-specific immunotherapy compositions for use in the treatment of house-dust mite allergy. |
US10548974B2 (en) | 2015-06-02 | 2020-02-04 | ROCA Medical Ltd. | Therapeutic treatment kit for allergies based on DNA profiles |
US10369215B2 (en) | 2015-06-02 | 2019-08-06 | ROCA Medical Ltd. | Predilution sets for distributing antigens |
US11524019B2 (en) | 2017-08-21 | 2022-12-13 | Glycom A/S | Synthetic composition for reducing allergy symptoms |
KR102107056B1 (ko) | 2017-09-22 | 2020-05-29 | 연세대학교 산학협력단 | 진드기에 대한 알레르기성 질환 진단용 조성물, 진드기에 대한 알레르기성 진단 방법, 및 진드기에 대한 알레르기성 질환을 예방 또는 치료하기 위한 조성물 |
KR102010436B1 (ko) * | 2018-02-28 | 2019-08-13 | 을지대학교 산학협력단 | 신규 알러지 반응 검사용 조성물 |
US11408895B1 (en) | 2018-04-09 | 2022-08-09 | Hob Biotech Group Corp., Ltd. | Allergen characterization, potent allergen product formulation, comprehensive allergen reagent, and allergy assay |
CA3126904A1 (en) | 2019-01-18 | 2020-07-23 | Ihi Corporation | Thrust foil bearing |
KR20230173406A (ko) | 2022-06-17 | 2023-12-27 | 연세대학교 산학협력단 | 세균이 감소된 집먼지 진드기의 사육 방법 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR6915418D0 (pt) | 1969-10-13 | 1973-03-13 | Synergistics Inc | Processo de preparacao de um composto antigeno de acaros e de seu soro e sua titulacao |
JP2787162B2 (ja) * | 1989-08-24 | 1998-08-13 | フマキラー株式会社 | 精製ダニアレルゲン |
US5512283A (en) * | 1990-07-06 | 1996-04-30 | Allergene, Inc. | Methods for the selective suppression of an immune response to dust mite der Pi |
JP2516842B2 (ja) * | 1991-02-06 | 1996-07-24 | アサヒビール株式会社 | ダニ抗原に対するモノクロ―ナル抗体とその利用 |
US20030059445A1 (en) * | 2001-03-01 | 2003-03-27 | Claude Andre | Process for cultivating mites, nutrient preparation for this process, and preparation of allergenic extracts from these mites |
FR2821623B1 (fr) | 2001-03-01 | 2003-05-30 | Stallergenes | Procede de culture d'acariens, preparation nutritive pour ce procede, et preparation d'extraits allergeniques a partir de ces acariens |
WO2003006030A1 (en) * | 2001-07-11 | 2003-01-23 | Smith C Steven | Novel composition and method for altering allergenic protein in the environment |
WO2004047793A1 (en) * | 2002-11-26 | 2004-06-10 | Alk-Abelló A/S | Pharmaceutical allergen product |
GB0305257D0 (en) | 2003-03-07 | 2003-04-09 | Exchem Plc | A cleaning brush |
ATE461278T1 (de) * | 2003-05-07 | 2010-04-15 | Chemo Sero Therapeut Res Inst | Verfahren zur reinigung des modifizierten hauptallergens von milben |
WO2005058474A1 (en) | 2003-12-19 | 2005-06-30 | Alk-Abelló A/S | Cryogranulation and storage method for active pharmaceutical agents |
JP2007277094A (ja) * | 2004-06-29 | 2007-10-25 | Chemo Sero Therapeut Res Inst | 改変ダニ主要アレルゲン含有医薬組成物 |
JP2007297279A (ja) * | 2004-06-30 | 2007-11-15 | Chemo Sero Therapeut Res Inst | ダニグループ1アレルゲンの改変体 |
US20060210590A1 (en) | 2005-02-03 | 2006-09-21 | Alk-Abello A/S | Minor allergen control to increase safety of immunotherapy |
EP2228656B1 (en) | 2005-09-15 | 2013-10-23 | Alk-Abelló A/S | Quantification of allergens |
WO2007051476A1 (en) | 2005-11-04 | 2007-05-10 | Alk-Abelló A/S | Use of a liquid allergy vaccine formulation for oromucosal administration |
CN100536918C (zh) * | 2006-01-09 | 2009-09-09 | 浙江我武生物科技有限公司 | 尘螨合剂 |
KR20090104133A (ko) * | 2007-01-30 | 2009-10-05 | 알크-아벨로 에이/에스 | 제2 집먼지 진드기 2군 알레르겐에 대한 알레르기를 치료하기 위한 제1 집먼지 진드기 2군 알레르겐의 용도 |
ES2366353T3 (es) | 2007-03-30 | 2011-10-19 | Alk-Abelló A/S | Procedimiento para producir ácaros. |
WO2009022154A2 (en) * | 2007-08-15 | 2009-02-19 | Circassia Limited | Peptide with multiple epitopes |
JP5263477B2 (ja) | 2007-10-12 | 2013-08-14 | 独立行政法人農業生物資源研究所 | ダニ抗原米 |
EP2436692B1 (en) * | 2008-03-25 | 2017-08-02 | Bial Industrial Farmaceutica, S.A. | Hypoallergenic hybrid proteins of major group 1 and 2 mite allergens for use in the treatment of allergies |
CN102186501A (zh) | 2008-10-15 | 2011-09-14 | 阿尔克-阿贝洛有限公司 | 用于变态反应疫苗的剂量递增给药的药学产品 |
KR101893156B1 (ko) * | 2010-06-03 | 2018-08-31 | 알크-아벨로 에이/에스 | 진드기 알레르겐 추출물(들)을 함유하는 의약품 및 그의 제조방법 |
US10059751B2 (en) * | 2013-12-23 | 2018-08-28 | Alk-Abelló A/S | Peptide combinations and uses thereof in treating dust mite allergy |
-
2011
- 2011-06-03 KR KR1020137000186A patent/KR101893156B1/ko active Application Filing
- 2011-06-03 CN CN201610325465.3A patent/CN105903012B/zh active Active
- 2011-06-03 AU AU2011260233A patent/AU2011260233C1/en active Active
- 2011-06-03 MX MX2012013892A patent/MX2012013892A/es active IP Right Grant
- 2011-06-03 CA CA2801125A patent/CA2801125A1/en active Pending
- 2011-06-03 KR KR1020187024065A patent/KR101936920B1/ko active IP Right Grant
- 2011-06-03 EP EP17182562.3A patent/EP3266460B1/en active Active
- 2011-06-03 EP EP19219404.1A patent/EP3662916A1/en active Pending
- 2011-06-03 CN CN201180030212.9A patent/CN103327988B/zh active Active
- 2011-06-03 JP JP2013512937A patent/JP6002663B2/ja active Active
- 2011-06-03 RU RU2016121600A patent/RU2710544C2/ru active
- 2011-06-03 US US13/701,614 patent/US9265824B2/en active Active
- 2011-06-03 EP EP11725665.1A patent/EP2575832B1/en active Active
- 2011-06-03 RU RU2012157737A patent/RU2593778C3/ru active Protection Beyond IP Right Term
- 2011-06-03 WO PCT/EP2011/059210 patent/WO2011151449A1/en active Application Filing
- 2011-12-07 US US13/314,024 patent/US9259464B2/en active Active
-
2013
- 2013-01-02 ZA ZA2013/00033A patent/ZA201300033B/en unknown
-
2016
- 2016-01-08 US US14/991,245 patent/US10874736B2/en active Active
- 2016-06-22 JP JP2016123614A patent/JP6404861B2/ja active Active
-
2018
- 2018-09-13 JP JP2018171751A patent/JP6559311B2/ja active Active
-
2019
- 2019-12-20 US US16/723,609 patent/US10842866B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2593778C3 (ru) | Фармацевтический продукт, содержащий экстракт(ы) аллергена клещей, и способ его получения | |
EA201390559A1 (ru) | Подавление иммунного ответа по типу гиперчувствительности неродственным антигеном, получаемым из материала-источника аллергенов | |
WO2016172134A3 (en) | Novel compounds | |
EA201301320A1 (ru) | 4-арил-n-фенил-1,3,5-триазин-2-амины, которые содержат сульфоксиминную группу | |
UA112296C2 (uk) | Сухий порошковий препарат, який містить інгібітор фосфодіестерази | |
CL2007002274A1 (es) | Compuestos derivados del acido (3-amino-1,2,3,4-tetrahidro-9h-carbazol-9-il)-acetico; composicion farmaceutica; y uso para la prevencion y/o tratamiento de enfermedades alergicas e inmunes, tales como asma, epoc y rinitis entre otras. | |
WO2014100779A8 (en) | Methods for production of platelets from pluripotent stem cells and compositions thereof | |
JP2013533855A5 (ru) | ||
BR112012009327A2 (pt) | análogos de heterociclil pirazolopirimidina como inibidores de jak | |
WO2012104263A3 (en) | 1,4 oxazines as bace1 and/or bace2 inhibitors | |
DK3045456T3 (da) | Bicyklisk substituerede uraciler og anvendelse heraf | |
BR112015002118A2 (pt) | 4-metil-2,3,5,9,9b-pentaaza-ciclopenta[a]naftalenos | |
EP3587400A3 (en) | Process for the preparation of a pde4 inhibitor | |
CY1116824T1 (el) | Ενωσεις πυρουβαμιδιου ως αναστολεις της αλλεργιογονου πεπτιδασης ομαδας 1 των ακαρεων σκονης | |
WO2014195803A3 (en) | Contiguous overlapping peptides for treatment of house dust mites allergy | |
WO2012041867A3 (en) | Combined antigen and dna vaccine for preventing and treating autoimmune diseases | |
WO2011152804A3 (en) | Process for dry powder formulations | |
AR087168A1 (es) | Compuesto derivado de pirimidina sulfonamida | |
ECSP12012102A (es) | Proceso para producir un extracto de alérgenos | |
EA201500513A1 (ru) | Продукт сомикронизации, включающий ацетат улипристала | |
JP2013523758A5 (ru) | ||
JP2009108025A5 (ru) | ||
RU2019110980A (ru) | Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением | |
MX2013012773A (es) | Sustancias farmacologicas, composiciones farmaceuticas y metodos para la preparacion de las mismas. | |
WO2015031198A3 (en) | Bendamustine pharmaceutical compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ND4A | Extension of patent duration |
Effective date: 20201221 |